Literature DB >> 4128408

Physicochemical and biological properties of human and canine plasmins.

Y Takeda, M Nakabayashi.   

Abstract

Three kinds of plasmin were found to be generated when plasminogen or [(125)I]plasminogen was incubated at 32 degrees C for longer than 20 min in urokinase and 50% glycerol. Each plasmin was then separated by G-200 or G-75 Sephadex filtration, and its physicochemical properties were determined. The molecular weights of the three plasmins as determined by G-200 Sephadex filtration were 125,000+/-5,000(SD), 63,000+/-2,000(SD), and 31,500+/-1,000(SD), and those by sodium dodecyl sulfate(SDS)-polyacrylamide electrophoresis were 130,000+/-5,000(SD), 64,000+/-3,000(SD), and 32,000+/-1,500(SD). It was also found that during the incubation of the smallest plasmin in SDS and beta-mercaptoethanol it was further split into two smaller pieces of about 16,000 mol wt and that polymer proteins of 95,000+/-2,000(SD) and 48,000+/-1,500(SD) mol wt were formed. Despite these differences in the molecular size of the three plasmins, the specific activity of each plasmin was closely similar and in case of human plasmins averaged 29+/-0.9(SD) CTA units/mg plasmin and in case of canine plasmins 8.5+/-0.54(SD) CTA units/mg plasmin. Then, using human plasmin of the smallest size (mol wt 31,500), the total plasma antiplasmin capacity was determined in 20 normal human plasma, which averaged 7.8+/-2(SD) CTA units of plasmin per milliliter plasma. Studies were next made of the affinity of human [(125)I]-plasmin of the smallest size with albumin, gamma globulin, alpha(2)-macroglobulin, alpha(1)-antitrypsin, fibrinogen, and fibrin. The results were 0%, 0%, 14.6+/-0.5(SD)%, 17.6+/-0.6(SD)%, 21+/-0.5(SD)%, and 20.5+/-0.6(SD)%, respectively, of [(125)I]plasmin available and were unaltered when the amount of [(125)I]plasmin was increased to twice and four times the original amount. Finally, the plasma disappearance half-life of canine [(125)I]plasmin of the smallest size was studied in five healthy dogs, which averaged 14.2+/-0.63(SD) h. These results support the concept that the combination between plasmin and plasmin inhibitors is reversible and indicate that fibrinogen and fibrin have greater affinities than alpha(2)-macroglobulin or alpha(1)-antitrypsin.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4128408      PMCID: PMC301449          DOI: 10.1172/JCI107533

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme.

Authors:  C M AMBRUS; G MARKUS
Journal:  Am J Physiol       Date:  1960-09

2.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

3.  BOVINE FIBRINOGEN WITHOUT DETECTABLE PLASMINOGEN.

Authors:  P BRAKMAN
Journal:  Anal Biochem       Date:  1965-04       Impact factor: 3.365

4.  The multiplicity of plasmin inhibitors in human serum, demonstrated by the effect of primary amino compounds.

Authors:  O D RATNOFF; I H LEPOW; L PILLEMER
Journal:  Bull Johns Hopkins Hosp       Date:  1954-04

5.  The kinetics of biological processes; special problems connected with the use of tracers.

Authors:  A K SOLOMON
Journal:  Adv Biol Med Phys       Date:  1953

6.  Comparison of caseinolytic and fibrinolytic assays for plasmin (fibrinolysin) in "fibrinolytic agents".

Authors:  K M Moser; M B Frey
Journal:  Thromb Diath Haemorrh       Date:  1966-01-31

7.  Generation of 125 I-labelled plasmin in dogs in response to venous injury.

Authors:  Y Takeda; T R Parkhill; M Nakabayashi
Journal:  Ciba Found Symp       Date:  1972

8.  Plasminogen- 125 I responses in dogs to a single injection of urokinase and typhoid vaccine and to vascular injury.

Authors:  Y Takeda
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

9.  Studies of the metabolism and distribution of fibrinogen in healthy men with autologous 125-I-labeled fibrinogen.

Authors:  Y Takeda
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

10.  The gel-filtration behaviour of proteins related to their molecular weights over a wide range.

Authors:  P Andrews
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

View more
  2 in total

1.  Studies on human plasma C1 inactivator-enzyme interactions. II. Structural features of an abnormal C1 inactivator from a kindred with hereditary angioneurotic edema.

Authors:  P C Harpel; T E Hugli; N R Cooper
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

2.  Urine plasmin-like substances as an index of kidney allograft rejections.

Authors:  K Fukao; N Kashiwagi; T Kajiwara; M Ishikawa; B Husberg; R Weil; T E Starzl
Journal:  Transplantation       Date:  1977-05       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.